IP Library Granted Patent US 10,577,642
Granted Patent B2
US 10,577,642 · App. 15/961,480 · Granted Mar 3, 2020

Method and apparatus for measuring protein post-translational modification

Inventors: Eva R. Birnbaum (Los Alamos, NM); Benjamin P. Warner (Los Alamos, NM); Sharon M. Baldwin (Santa Fe, NM); Jennifer A. Berger (Los Alamos, NM); Lori J. Peterson-Court (Los Alamos, LA); Michael N. Harris (Los Alamos, NM); Rebecca L. E. Miller (Los Alamos, NM)
Assignee: Icagen, Inc.
C12Q1/485C12Q1/37G01N21/75G01N23/223G01N33/20G01N33/6842G01N2223/076G01N2333/91215G01N2333/96441Y10T436/17Y10T436/200833
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,577,642
App. No.
15/961,480
Granted
Mar 3, 2020
Kind
B2
Abstract

The present invention includes a method for analyzing reactions. The method includes the steps of providing a solution of at least one acceptor chemical and at least one donor chemical. The donor chemical is capable of donating a chemical moiety to the acceptor chemical. The solution further includes at least one controller chemical that affects the reaction between the donor chemical and the acceptor chemical. The solution is then incubated so that a portion of the acceptor chemical reacts with the donor chemical to form an acceptor product. Unreacted donor chemical is separated from the acceptor product. The acceptor product or the donor chemical is then measured using X-ray fluorescence. Another aspect of the present invention includes a method for analyzing protein function. The method includes the steps of providing a solution of at least one acceptor chemical and at least one donor chemical. The donor chemical is capable of donating a chemical moiety to the acceptor chemical. The donor chemical includes a functional group selected from ester, anhydride, imide, acyl halide, and amide. The solution is then incubated so that a portion of the acceptor chemical reacts with the donor chemical to form an acceptor product. Unreacted donor chemical is separated from the acceptor product. The acceptor product or the donor chemical is then measured using X-ray fluorescence. Yet another aspect of the present invention includes a method for analyzing protein function. The method includes the steps of providing a solution of at least one acceptor chemical and at least one donor chemical. The solution is then incubated so that a portion of the acceptor chemical reacts with the donor chemical to form an acceptor product. Unreacted donor chemical is separated from the acceptor product. The acceptor product or the donor chemical is then measured using X-ray fluorescence. An additional analytical method is also used to measure either the acceptor product or the donor chemical.

Claims (21)

1. A method for analyzing reactions, comprising:

(a) providing a solution comprising solvent, at least one acceptor chemical and at least one donor chemical, wherein the donor chemical is capable of donating a chemical moiety comprising a chemical element to the acceptor chemical, and at least two controller chemicals capable of affecting the reaction between the donor chemical and the acceptor chemical;

(b) incubating the solution to allow a portion of the acceptor chemical to react with the donor chemical to form an acceptor product;

(c) separating at least a portion of the unreacted donor chemical from the acceptor product;

(d) removing at least a portion of the solvent before measuring using x-ray fluorescence at least one of the chemicals selected from the list of acceptor product and the donor chemical; and

(e) measuring using x-ray fluorescence at least one of the acceptor product or the donor chemical, wherein:

the controller chemicals are selected from the group consisting of amino acids, lipids, reactive oxygen species and reactive nitrogen species; and

the sample of donor chemical or acceptor product that is subjected to x-ray fluorescence measurement is concentrated such that the area containing more than 50% of the sample based on the total amount of the sample of donor chemical or acceptor product that is subjected to x-ray fluorescence measurement is less than 0.005 square centimeters.

2. The method of claim 1 , further comprising:

measuring using at least one additional analytical method at least one of the acceptor product or the donor chemical.

3. The method of claim 1 , wherein the step of removing at least a portion of the solvent is performed using reduced pressure.

4. The method of claim 1 , wherein at least 80% of the solvent is removed.

5. The method of claim 4 , wherein the step of separating at least a portion of the unreacted donor chemical from the acceptor product is performed using chromatography.

6. The method of claim 4 , wherein the step of separating at least a portion of the unreacted donor chemical from the acceptor product is performed using a centrifuge.

7. The method of claim 4 , wherein the step of separating at least a portion of the unreacted donor chemical from the acceptor product is performed using size exclusion chromatography.

8. The method of claim 1 , wherein the reaction between the donor chemical and the acceptor chemical forms at least one chemical bond.

9. The method of claim 1 , wherein the reaction between the donor chemical and the acceptor chemical breaks at least one bond.

10. The method of claim 1 , wherein the controller chemical is an amino acid.

11. The method of claim 1 , wherein the controller chemical is a reactive oxygen species.

12. The method of claim 1 , wherein the controller chemical is a reactive nitrogen species.

13. The method of claim 1 , wherein the controller chemical is a lipid.

Assignments (11)
CONFIRMATORY LICENSE Recorded Sep 19, 2024
From: CALDERA PHARMACEUTICALS
To: UNITED STATES GOVERNMENT
Reel/Frame 068629/0646 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2021
From: ICAGEN, INC.; ICAGEN CORP.; XRPRO SCIENCES, INC.; CALDERA DISCOVERY, INC.
To: ADJACENT ACQUISITION CO., LLC
Reel/Frame 055903/0125 →
CHANGE OF NAME Recorded Apr 13, 2021
From: ADJACENT ACQUISITION CO., LLC
To: ICAGEN, LLC
Reel/Frame 055910/0905 →
RELEASE OF SECURITY INTEREST Recorded Apr 3, 2020
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: ICAGEN, INC.; ICAGEN CORP.; CALDERA DISCOVERY, INC.; XRPRO SCIENCES, INC.
Reel/Frame 052304/0304 →
RELEASE OF SECURITY INTEREST Recorded Apr 3, 2020
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: ICAGEN-T, INC.; ICAGEN CORP.; CALDERA DISCOVERY, INC.; XRPRO SCIENCES, INC.; ICAGEN, INC.
Reel/Frame 052304/0712 →
CHANGE OF NAME Recorded Dec 3, 2019
From: XRPRO SCIENCES, INC.
To: ICAGEN, INC.
Reel/Frame 051198/0647 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2019
From: BIRNBAUM, EVA R.; WARNER, BENJAMIN P.; BALDWIN, SHARON M.; BERGER, JENNIFER A.; PETERSON-COURT, LORI J.; HARRIS, MICHAEL N.; MILLER, REBECCA L. E.
To: CALDERA PHARMACEUTICALS, INC.
Reel/Frame 051162/0771 →
CHANGE OF NAME Recorded Dec 3, 2019
From: CALDERA PHARMACEUTICALS. INC
To: XRPRO SCIENCES, INC.
Reel/Frame 051169/0438 →
SECURITY AGREEMENT Recorded Sep 5, 2018
From: ICAGEN, INC.; ICAGEN CORP.; CALDERA DISCOVERY, INC.; XRPRO SCIENCES, INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 047016/0859 →
SECURITY AGREEMENT Recorded Sep 5, 2018
From: ICAGEN-T, INC.; ICAGEN CORP.; CALDERA DISCOVERY, INC.; XRPRO SCIENCES, INC.; ICAGEN, INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 047317/0860 →
CONFIRMATORY LICENSE Recorded Jun 20, 2018
From: CALDERA PHARMACEUTICALS
To: DEFENSE THREAT REDUCTION AGENCY, US DOD
Reel/Frame 046137/0317 →
Continuity (4)
Continuation 15052914 · Feb 25, 2016
Continuation 12239459 · Sep 26, 2008
Provisional Application 60995997 · Sep 28, 2007
Related Publication 20180237823A1 · Aug 23, 2018